Eric joined MVM in 2008. Before joining MVM, Eric was a Partner at Advent Healthcare Ventures and a Principal at Advent International Corporation. Prior to Advent, Eric was a Director in the Corporate Finance Group of Silicon Valley Bank. Eric has a B.S. degree in Neural Science from Brown University and a Ph.D. in Biological Sciences from the University of California, Irvine.
Eric is a member of the boards of Ambio, Inc., bioTheranostics, Inc., Solx, Inc. and Tarsa Therapeutics, Inc. He was previously a director of AccuVein, Inc. and Heptares Ltd (acquired by Sosei Group Corporation) and was MVM’s representative for its investment in Aegerion (NASDAQ: AEGR).
MVM Life Science Partners
Old City Hall
45 School Street
Boston MA 02108